Clinical Research Program and COVID-19 Collaboration Launched in Nigeria
54gene has launched a clinical research program in Nigeria to discover, develop, and commercialize new therapeutic and diagnostic products.
Related Articles
Obesity Treatments Might Target a Protein for Cooling Brown Fat’s Burn
Genetically depleting AC3-AT protected mice from obesity as they were better able to burn calories and increased their metabolic rates through activating brown fat.
Online Event
Quantitative real-time PCR (qPCR) and digital PCR (dPCR) are powerful molecular biology techniques for quantifying and analyzing DNA or RNA, but they differ in their…
FDA Clears Prime Medicine’s IND for First Prime Editing Therapy
Prime Medicine said it has gained FDA clearance for the first human trials of a prime editing therapy as the agency has approved an investigational…
Online Event
Developing a biosimilar drug requires screening many samples originating from different cell lines to select the most appropriate ones for further process development. Each sample…
Cancer Can Form without Genetic Mutations, Just Epigenetic Changes
Tumors of epigenetic, not genetic, origin have been demonstrated, challenging the established idea that cancer is caused only by permanent changes to DNA
FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B
The BEQVEZ gene therapy inserts a working copy of the Factor IX (FIX) gene that codes for a high-activity FIX variant.
Bird Flu: What We Know So Far about H5N1 in the United States
What we know so far about the H5N1 influenza strain, otherwise known as “bird flu” or “avian flu,” and its spread in the United States.
Online Event
About five million people in the United States alone live with traumatic brain injuries (TBIs). These injuries can quadruple the risk of developing Alzheimer’s disease,…
The Difference Is the Data: Drug Discovery’s AI Revolution
New data-intensive platforms continue to leverage artificial intelligence tools for improved speed and failure rate reductions for drug discovery.
Giant Virus That Infects Naegleria fowleri Isolated from Viennese Wastewater
A giant virus that replicates in the human pathogen single-celled organism Naegleria fowleri has been discovered.